Avelumab (active substance) - analogs
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
| Prices in pharmacies: Instructions Avelumab | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 35% Prolgolimab
- 31% Ipilimumab
- 30% Cobimetinib
- 30% Vemurafenib
- 30% Miltefosine
- 30% Dabrafenib
- 30% Lapatinib
- 30% Larotrectinib
- 30% Nurulimab+Prolgolimab [Prolgolimab]
- 28% Pertuzumab
- 28% Catumaxomab
- 28% Teclistamab
- 25% Durvalumab
- 25% Isatuximab
- 24% Trastuzumab
- 24% Apalutamide
- 24% Vaccinum for immunotherape cancer of vesica urinaria
- 24% Hexylaminolevulinate
- 24% Darolutamide
- 24% Streptozocin
- 23% Obinutuzumab
- 23% Blinatumomab
- 23% Inotuzumab ozogamicin
- 23% Elotuzumab
- 23% Tremelimumab
- 22% Trastuzumab emtansine
- 22% Pembrolizumab
- 20% Enzalutamide
- 20% Osimertinib
- 20% Abiraterone
- 20% Daratumumab
- 20% Ribociklib
- 20% Gefitinib
- 20% Drostanolone
- 20% Ceritinib
- 20% Tiludronic acid
- 20% Afatinib
- 20% Capmatinib
- 20% Epcoritamab
- 20% Polatuzumab vedotin
- 19% Nivolumab
- 19% Panitumumab
- 18% Glofitamab
- 17% Exemestane
- 17% Fulvestrant
- 17% Binimetinib
- 17% Fotemustine
- 17% Vandetanib
- 17% Demecolcine
- 17% Ofatumumab
Learn more about the selection of analogues
▶
- The drug has «Avelumab» 51 analog by action, the most similar - Prolgolimab .
- Medical online service has selected the best substitutes for Avelumab based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Avelumab to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.